HUICHENG INTL H(01146): Huang Xiaoyun and He Jiahong appointed as members of the nomination committee.
Hui Cheng International Holdings Limited (01146) has announced that Ms. Huang Xiaoyun, an executive director, and Mr. He Jiahong, an independent non-executive director, have been appointed as members of the company's Nomination Committee, effective from December 9, 2025.
Huicheng International (01146) announced that Ms. Huang Xiaoyun, an executive director, and Mr. He Jiahong, an independent non-executive director, have been appointed as members of the Nomination Committee of the company, effective December 9, 2025.
Related Articles
Shenyang Xingqi Pharmaceutical (300573.SZ): The first subject enrolled in the clinical trial of SQ-22031 eye drops for the treatment of moderate to severe dry eye syndrome stage II.
Xuanwu Cloud (02392) spent HK$2263.27 on December 9 to repurchase 2000 shares.
Shareholder Zhang Yunlan of Qingdao Kutesmart Co., Ltd. (300840.SZ) plans to reduce their shareholding by not more than 2%.
Shenyang Xingqi Pharmaceutical (300573.SZ): The first subject enrolled in the clinical trial of SQ-22031 eye drops for the treatment of moderate to severe dry eye syndrome stage II.
Xuanwu Cloud (02392) spent HK$2263.27 on December 9 to repurchase 2000 shares.
Shareholder Zhang Yunlan of Qingdao Kutesmart Co., Ltd. (300840.SZ) plans to reduce their shareholding by not more than 2%.
RECOMMEND
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
As The 2025 Central Economic Work Conference Approaches, What New Expectations Lie Ahead For Next Year’s Economic Agenda? Institutions Forecast Five Key Highlights
08/12/2025
